Benefits
Boosts non-heme iron absorption from food
Lp299v consistently increases iron absorption from plant-source (non-heme) iron meals — pooled across multiple trials, the relative absorption boost is about 17%. Practical translation: more of the iron you eat reaches your bloodstream. Most useful for vegetarians and vegans, women of reproductive age, athletes, and anyone with marginal iron status. Doesn't replace iron supplementation when treating actual deficiency, but pairs naturally with iron-rich meals or low-dose iron.
Improves iron status in iron-depleted athletes
In female athletes with low iron stores (ferritin under 30 μg/L) but no anemia yet, Lp299v combined with 20 mg iron raises ferritin faster and higher than 20 mg iron alone over 12 weeks. The effect is most pronounced in the lowest-ferritin subgroup. Useful for endurance athletes who are notoriously prone to functional iron deficiency from training-induced inflammation and gastrointestinal iron loss. Best treated as an enhancer of existing iron supplementation, not a standalone.
Reduces iron deficiency in pregnancy
When taken from early pregnancy with low-dose iron (4.2 mg), folic acid, and vitamin C, Lp299v cuts iron deficiency from 78% to 59% by late pregnancy and reduces iron deficiency anemia from 21% to 7.4%. Important: this is at low iron doses — Lp299v's value is making minimal iron go further, with fewer GI side effects than the higher iron doses typically recommended in pregnancy. A reasonable strategy for women who don't tolerate standard prenatal iron levels.
IBS symptom relief — modest
In irritable bowel syndrome, Lp299v produces modest improvements in abdominal pain, bloating, and stool consistency across multiple trials. Effect size is meaningful but not dramatic — comparable to other evidence-based IBS probiotics rather than transformative. A reasonable trial in IBS, particularly for bloating-predominant symptoms. Set expectations realistically: benefit usually shows within 4-6 weeks; if no improvement by 8 weeks, it's probably not your strain.
Mechanism of action
Ferric iron stabilization in gut lumen
Lp299v has been shown to increase the amount of ferric iron (Fe³⁺) in in vitro digested meals and drinks. Combined with lower gut pH from lactic and acetic acid production, this creates more favorable conditions for iron solubilization and absorption — particularly important for plant-source iron in vegetarian/vegan diets.
Lactic and acetic acid production
Lp299v ferments dietary carbohydrates to lactic and acetic acid, lowering local pH. This both enhances iron solubility and inhibits pathogenic bacteria. The acid production may also activate phytases and reduce phytate-iron complexes that normally limit non-heme iron bioavailability.
Gut epithelial barrier and mucin support
Lp299v increases mucin (MUC2, MUC3) gene expression in gut epithelial cells, supporting the protective mucus barrier. This is one mechanism for the strain's IBS benefits and for reducing pathogen adhesion. Also implicated in athlete performance studies showing reduced GI distress.
Clinical trials
Evidence review and pooled analysis (Vonderheid, Tussing-Humphreys, Park, Pauls, Hemphill, LaBomascus, McLeod, Nutrients 11(12):2938).
8 trials examining Lp299v iron absorption effect (15 total studies on probiotics and iron, N=950 across all studies). Random-effects pooled analysis on the Lp299v subset.
Pooled standardized mean difference of 0.55 (95% CI 0.22-0.88, p=0.001) demonstrating significant iron absorption increase with Lp299v. Of all probiotic strains examined, only Lp299v consistently showed iron absorption benefit. Authors concluded Lp299v is the only probiotic with sufficient evidence to recommend for iron absorption support.
Randomized, double-blind, placebo-controlled, parallel study (Axling, Önning, Combs, Bogale, Högström, Nutrients 12(5):1279).
53 healthy non-anemic female athletes with low iron stores (ferritin <30 μg/L), 39 completed. Randomized to 10¹⁰ CFU Lp299v + 20 mg iron OR 20 mg iron alone, daily for 12 weeks.
Lp299v + iron group showed greater and more rapid ferritin increases than iron alone. Effect was particularly pronounced in subjects with baseline ferritin <20 μg/L. Mood state and physical performance markers also showed improvements. Established that Lp299v can reduce required iron supplement dosing while improving iron status.
Single-blind crossover trial using double isotope (⁵⁵Fe and ⁵⁹Fe) technique (Hoppe, Önning, Berggren, Hulthén 2015, Br J Nutr 114(8):1195-1202).
Healthy women of reproductive age. Trial 1: 10⁹ CFU Lp299v vs control fruit drink. Trial 2: 10¹⁰ CFU Lp299v vs control. ~5 mg iron as ferrous lactate per drink.
Both 10⁹ and 10¹⁰ CFU doses of Lp299v significantly enhanced non-heme iron absorption from a fortified fruit drink compared to the same drink without Lp299v. Established the dose range for the benefit and demonstrated efficacy with both viable doses.
Randomized, double-blind, placebo-controlled study (Axling, Hoekstra, Önning et al 2021, J Intern Med 290(5):1027-1041).
326 healthy non-anemic pregnant Swedish women. Randomized to Lp299v (10¹⁰ CFU) + 4.2 mg iron + 12 mg ascorbic acid + 30 μg folic acid OR placebo, twice daily from gestational week 10-12 until end of pregnancy.
Lp299v group showed significantly smaller ferritin decreases at week 28 (p=0.003) and week 35 (p<0.001). Iron deficiency prevalence reduced from 78% to 59% (p=0.017). Iron deficiency anemia reduced from 21% to 7.4% (p=0.023) at week 35. Demonstrated clinically important benefits with low-dose iron — addressing the GI tolerance issues of standard pregnancy iron supplementation.